Synthetic statins: More data on newer lipid-lowering agentsWIERZBICKI, Anthony S.Current medical research and opinion. 2001, Vol 17, Num 1, pp 74-77, issn 0300-7995Article

Hyperlipidaemia in Paediatric Patients: The Role of Lipid-Lowering Therapy in Clinical PracticeWIERZBICKI, Anthony S; VILJOEN, Adie.Drug safety. 2010, Vol 33, Num 2, pp 115-125, issn 0114-5916, 11 p.Article

Lipemia retinalisKUMAR, Jesse; WIERZBICKI, Anthony S.The New England journal of medicine. 2005, Vol 353, Num 8, issn 0028-4793, p. 823Article

Investigating mixed hyperlipidaemiaVILJOEN, Adie; WIERZBICKI, Anthony S.BMJ (Overseas and retired doctors ed.). 2011, Vol 343, Num 7821, pp 477-478, issn 1759-2151, 2 p.Article

New Lipid Modulating Drugs: The Role of Microsomal Transport Protein InhibitorsRIZZO, Manfredi; WIERZBICKI, Anthony S.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 943-949, issn 1381-6128, 7 p.Article

Beyond LDL-C - the importance of raising HDL-CWIERZBICKI, Anthony S; MIKHAILIDIS, Dimitri P.Current medical research and opinion. 2002, Vol 18, Num 1, pp 36-44, issn 0300-7995Article

Familial hypercholesterolaemia : summary of NICE guidanceWIERZBICKI, Anthony S; HUMPHRIES, Steve E; MINHAS, Rubin et al.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7668, pp 509-511, issn 0959-8146, 3 p.Article

Usefulness of orlistat in the treatment of severe hypertriglyceridemiaWIERZBICKI, Anthony S; REYNOLDS, Timothy M; CROOK, Martin A et al.The American journal of cardiology. 2002, Vol 89, Num 2, pp 229-231, issn 0002-9149Article

Relation of erectile dysfunction to angiographic coronary artery diseaseSOLOMON, Hemant; MAN, Jonathan W; WIERZBICKI, Anthony S et al.The American journal of cardiology. 2003, Vol 91, Num 2, pp 230-231, issn 0002-9149, 2 p.Article

Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A_1cTWOMEY, Patrick J; WIERZBICKI, Anthony S; REYNOLDS, Timothy M et al.Current medical research and opinion. 2003, Vol 19, Num 8, pp 719-723, issn 0300-7995, 5 p.Article

Getting better value from the NHS drugs budgetMOON, James; FLETT, Andrew S; GODMAN, Brian B et al.BMJ (Overseas and retired doctors ed.). 2011, Vol 342, Num 7787, pp 30-32, issn 1759-2151, 3 p.Article

Cardiovascular risk factors determine erectile and arterial function response to sildenafilSOLOMON, Hemant; WIERZBICKI, Anthony S; LUMB, Peter J et al.American journal of hypertension. 2006, Vol 19, Num 9, pp 915-919, issn 0895-7061, 5 p.Article

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidanceRABAR, Silvia; HARKER, Martin; O'FLYNN, Norma et al.BMJ (Overseas and retired doctors ed.). 2014, Vol 349, Num 7968, pp 38-41, issn 1759-2151, 4 p.Article

Copper : caeruloplasmin ratioTWOMEY, Patrick J; VILJOEN, Adie; HOUSE, Ivan M et al.Journal of clinical pathology. 2007, Vol 60, Num 4, pp 441-442, issn 0021-9746, 2 p.Article

Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine Clinical PracticeTWOMEY, Patrick J; VILJOEN, Adie; HOUSE, Ivan M et al.Clinical chemistry (Baltimore, Md.). 2005, Vol 51, Num 8, pp 1558-1559, issn 0009-9147, 2 p.Article

Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemiaWIERZBICKI, Anthony S; LAMBERT-HAMMILL, Michelle; LUMB, Peter J et al.Hypertension (Dallas, Tex. 1979). 2000, Vol 36, Num 5, pp 808-812, issn 0194-911XArticle

Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationWATTS, Gerald F; GIDDING, Samuel; MATA, Pedro et al.International journal of cardiology. 2014, Vol 171, Num 3, pp 309-325, issn 0167-5273, 17 p.Article

Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemiaCLARKE, Rosemary E. J; PADAYACHEE, Soundrie T; PRESTON, Rebecca et al.Heart (London 1996). 2013, Vol 99, Num 3, pp 175-180, issn 1355-6037, 6 p.Article

Identification of PEX7 as the second gene involved in Refsum diseaseVAN DEN BRINK, Daan M; BRITES, Pedro; HAASJES, Janet et al.American journal of human genetics. 2003, Vol 72, Num 2, pp 471-477, issn 0002-9297, 7 p.Article

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: Association with serum sex steroid concentrations and bone mineral density in postmenopausal womenSOMNER, John; MCLELLAN, Susan; HAMPSON, Geeta N et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 1, pp 344-351, issn 0021-972X, 8 p.Article

Cardiovascular risk factors and endothelial dysfunctionWIERZBICKI, Anthony S; CHOWIENISZYK, Philip J; COCKCROFT, John R et al.Clinical science (1979). 2004, Vol 107, Num 6, pp 609-615, issn 0143-5221, 7 p.Article

Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemiaWIERZBICKI, Anthony S; HARDMAN, Timothy C; CHEUNG, Joseph et al.American journal of hypertension. 2001, Vol 14, Num 1, pp 32-37, issn 0895-7061Article

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's diseaseMUKHERJI, Mridul; CHIEN, Winnie; KERSHAW, Nadia J et al.Human molecular genetics (Print). 2001, Vol 10, Num 18, pp 1971-1982, issn 0964-6906Article

Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young black African menMELIKIAN, Narbeh; WHEATCROFT, Stephen B; KEARNEY, Mark T et al.Hypertension (Dallas, Tex. 1979). 2007, Vol 49, Num 4, pp 873-877, issn 0194-911X, 5 p.Article

Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency : a stable isotope studyCHRIST, Emanuel R; CUMMINGS, Michael H; STOLINSKI, Michael et al.European journal of endocrinology. 2006, Vol 154, Num 3, pp 459-466, issn 0804-4643, 8 p.Article